Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 14 min ago
Peer-reviewedLicence not statedPharmaceutical research

Development of an In Vitro Permeation Test Framework For Naloxone Hydrochloride Intranasal Spray: Establishing IVIVR for Bioequivalence Assessment

  • Tasmin Ara Sultana1
  • Manar Al-Ghabeish2
  • Steven Chopski3
  • Ross Walenga3
  • Diaa Shakleya1
  • Bryan Newman4
  • Muhammad Ashraf1
  • Ahmed Zidan1
4 affiliations
  1. 1Division of Pharmaceutical Quality Research V, Office of Pharmaceutical Quality Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA
  2. 2Division of Therapeutic Performance II, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA
  3. 3Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA
  4. 4Division of Therapeutic Performance I, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA
Read full textDOICite

Related

  1. Bioequivalence study of two formulations of a sitagliptin/metformin hydrochloride extended-release tablet in healthy Chinese subjects under fasting and fed conditions: a randomized, open-label, single-dose, crossover trial
    Lin Fang, Xin Li, Rongxin Ban +6
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefEurope PMCPMC
  2. Development of cinnarizine nanoemulsion for enhanced topical delivery with ex vivo permeation and in vivo pharmacodynamic evaluation
    Rania Al-Hamwi, Mohammad Ali Zrir, Hind El-Zein
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textPharmacology & toxicologyCrossref
  3. Development of a Multivalent Macrocyclic Peptide that Protects Against SARS-CoV-2 Infection Following Intranasal Administration
    Antonius J.P. Hopstaken, Aneta Zegar, Oliver J. Debski-Antoniak +13
    ChemRxivPreprintCC BYFull textInfectious diseaseChemRxiv
  4. Bioequivalence of tegomil fumarate gastro-resistant capsules versus dimethyl fumarate gastro-resistant capsules under different fed conditions: two randomized, crossover, phase I studies
    Katja Zietz, Simona Rizea Savu, Lina Remis +3
    Frontiers in neurologyPeer-reviewedCC BYFull textNeurologyEurope PMC
  5. A 3D-printed diffusion cell for nail permeation testing
    Stanislas Maisonneuve, Sandy Vrignaud, Marc Pihet +4
    International Journal of PharmaceuticsPeer-reviewedPublisher termsFull textEpidemiology & public healthHAL

Cite

BibTeXRIS
BibTeX
@article{sultana2026development,
  title = {{Development of an In Vitro Permeation Test Framework For Naloxone Hydrochloride Intranasal Spray: Establishing IVIVR for Bioequivalence Assessment}},
  author = {Tasmin Ara Sultana and Manar Al-Ghabeish and Steven Chopski and Ross Walenga and Diaa Shakleya and Bryan Newman and Muhammad Ashraf and Ahmed Zidan},
  journal = {Pharmaceutical research},
  year = {2026},
  month = jul,
  doi = {10.1007/s11095-026-04153-w},
  url = {https://doi.org/10.1007/s11095-026-04153-w},
}
RIS
TY  - JOUR
TI  - Development of an In Vitro Permeation Test Framework For Naloxone Hydrochloride Intranasal Spray: Establishing IVIVR for Bioequivalence Assessment
AU  - Tasmin Ara Sultana
AU  - Manar Al-Ghabeish
AU  - Steven Chopski
AU  - Ross Walenga
AU  - Diaa Shakleya
AU  - Bryan Newman
AU  - Muhammad Ashraf
AU  - Ahmed Zidan
PY  - 2026
DA  - 2026/07/30
JO  - Pharmaceutical research
DO  - 10.1007/s11095-026-04153-w
UR  - https://doi.org/10.1007/s11095-026-04153-w
SN  - 0724-8741
SN  - 1573-904X
ER  -